Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysregulation of complement at the synapse in P301S mice and human tauopathies.

Acta neuropathologica communications·2026
Same author

Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID.

Immunology·2026
Same author

Absence of complement terminal pathway activity in C6-deficient mice prolongs survival in a mouse model of severe malarial infection.

Immunobiology·2025
Same author

CD59, Disulphide-Locked Human C9 and Horse C9 Inhibit Human Membrane Attack Complex Assembly by Similar Mechanisms.

Immunology·2025
Same author

Complement dysregulation in human tauopathies.

Brain pathology (Zurich, Switzerland)·2025
Same author

Plasma complement system markers and their association with cardiometabolic risk factors: an ethnic comparison of White European and Black African men.

American journal of physiology. Endocrinology and metabolism·2025

Related Experiment Video

Updated: Jun 6, 2026

Murine Model of Intestinal Ischemia-reperfusion Injury
07:07

Murine Model of Intestinal Ischemia-reperfusion Injury

Published on: May 11, 2016

Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by

Tomohiro Mizuno1, Masashi Mizuno, B Paul Morgan

  • 1Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|November 25, 2010
PubMed
Summary

Complement regulators Crry and CD59 control peritoneal inflammation during dialysis. Blocking these regulators causes injury, highlighting their importance in preventing peritoneal inflammation in patients undergoing peritoneal dialysis.

More Related Videos

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Experiment Videos

Last Updated: Jun 6, 2026

Murine Model of Intestinal Ischemia-reperfusion Injury
07:07

Murine Model of Intestinal Ischemia-reperfusion Injury

Published on: May 11, 2016

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Area of Science:

  • Immunology
  • Renal Physiology
  • Cell Biology

Background:

  • The peritoneal cavity is a sterile environment crucial for peritoneal dialysis (PD).
  • Unregulated complement activation can cause peritoneal inflammation in PD patients.
  • Membrane complement regulators (CRegs) like Crry, CD55, and CD59 are present in the rat peritoneum.

Purpose of the Study:

  • To investigate the functional roles of CRegs in the peritoneal cavity.
  • To understand how CRegs control complement activation in the context of PD.

Main Methods:

  • Utilized blocking monoclonal antibodies against individual CRegs (Crry, CD55, CD59).
  • Assessed complement activation and peritoneal injury in rats with varying peritoneal dialysis fluid (PDF) compositions.
  • Confirmed findings using in vitro experiments with primary rat mesothelial cells.

Main Results:

  • Blocking a single CReg did not induce peritoneal injury.
  • Combined blockade of Crry and CD59 led to significant peritoneal tissue injury, inflammation, and edema.
  • Complement components C3 and C5b-9 deposition occurred after combined Crry and CD59 blockade.
  • Peritoneal injury was exacerbated by lower PDF pH and higher glucose concentrations.
  • In vitro studies corroborated the in vivo findings.

Conclusions:

  • Rat CRegs, specifically Crry and CD59, work together to regulate complement activation in the peritoneum.
  • Impairment of these CRegs during PD may lead to severe peritoneal inflammation.